Descovy Granted Expanded Pediatric Indication for HIV
January 7, 2022Viona Pharmaceuticals Recalls Metformin Due to NDMA
January 7, 2022January 7, 2022 – The U.S. FDA has updated emergency use authorization for Moderna's COVID-19 vaccine to shorten the time between the primary vaccination series and receipt of a booster dose.
- Originally, the booster dose was authorized to be given six months following the completion of a primary vaccination series. It can now be given five months following primary vaccination.
- Moderna's vaccine can be used to provide a booster dose after completing primary vaccination with the Janssen COVID-19 vaccine, the Moderna COVID-19 vaccine, or Pfizer’s Comirnaty. It is authorized for use in individuals who are at least 18 years old.